Overall, our data do not support the view that skeletal muscle PPARGC1A promoter methylation plays any major causal role in the pathogenesis of T2D, at least not among individuals with a family history of T2D. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.